UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000048642
Receipt No. R000055393
Scientific Title Risk Factors for Lymph Node Metastasis of Colorectal T2 Cancer and Prediction Model for Metastasis Using Virtual Slides
Date of disclosure of the study information 2022/10/01
Last modified on 2022/08/10 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Risk Factors for Lymph Node Metastasis of Colorectal T2 Cancer and Prediction Model for Metastasis Using Virtual Slides
Acronym Risk Factors for Lymph Node Metastasis of Colorectal T2 Cancer and Prediction Model for Metastasis Using Virtual Slides
Scientific Title Risk Factors for Lymph Node Metastasis of Colorectal T2 Cancer and Prediction Model for Metastasis Using Virtual Slides
Scientific Title:Acronym Risk Factors for Lymph Node Metastasis of Colorectal T2 Cancer and Prediction Model for Metastasis Using Virtual Slides
Region
Japan

Condition
Condition colorectal cancer
Classification by specialty
Gastroenterology Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Extraction of Risk Factors for Lymph Node Metastasis in Colorectal T2 Cancer. Construction of Artificial Intelligence to Predict Lymph Node Metastasis from Pathological Images.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Diagnostic ability (sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and area under the curve) for lymph node metastasis
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Surgical resected colon tumor
Key exclusion criteria Cases with difficult pathological evaluation
Target sample size 700

Research contact person
Name of lead principal investigator
1st name Yuta
Middle name
Last name Kouyama
Organization Showa University Northern Yokohama Hospital
Division name Digestive Disease Center
Zip code 224-8503
Address 35-1, Chigasakityuo, Tsuzuki-ku, Yokohama-shi, Kanagawa-ken, Japan
TEL 045-949-7000
Email kouyuta1101@yahoo.co.jp

Public contact
Name of contact person
1st name Yuta
Middle name
Last name Kouyama
Organization Showa University Northern Yokohama Hospital
Division name Digestive Disease Center
Zip code 224-8503
Address 35-1, Chigasakityuo, Tsuzuki-ku, Yokohama-shi, Kanagawa-ken, Japan
TEL 045-949-7000
Homepage URL
Email kouyuta1101@yahoo.co.jp

Sponsor
Institute Digestive Disease Center, Showa University Northern Yokohama Hospital
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Showa University
Address 1-5-8, hatanodai, Shinagawa-ku, Tokyo, Japan
Tel 03-3784-8000
Email m-rinri@ofc.showa-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 10 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 06 Month 30 Day
Date of IRB
2022 Year 07 Month 21 Day
Anticipated trial start date
2022 Year 07 Month 21 Day
Last follow-up date
2024 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Accumulating pathological preparation images, and constructing AI.

Management information
Registered date
2022 Year 08 Month 10 Day
Last modified on
2022 Year 08 Month 10 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055393